We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$627M
AUM Growth
+$7.5M
Cap. Flow
+$6.68M
Cap. Flow %
1.07%
Top 10 Hldgs %
17.82%
Holding
446
New
23
Increased
113
Reduced
92
Closed
35

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$5.01M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$4.48M
3
STKL
SunOpta
STKL
+$4.27M
4
HUBB icon
Hubbell
HUBB
+$3.83M
5
AXGN icon
Axogen
AXGN
+$3.28M

Sector Composition

Rank Sector Weight
1 Technology 25.48%
2 Industrials 19.31%
3 Healthcare 16.3%
4 Materials 9.29%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATEC icon
101
Alphatec Holdings
ATEC
$1.49B
$1.93M 0.31%
221,003
+6,196
+3% +$49K
JPM icon
102
JPMorgan Chase
JPM
$971B
$1.87M 0.3%
17,905
-1,914
-10% -$220K
RVNC
103
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.85M 0.3%
68,622
+5,034
+8% +$102K
DDD icon
104
3D Systems Corp
DDD
$603M
$1.83M 0.29%
229,954
+29,525
+15% +$303K
SSTI icon
105
SoundThinking
SSTI
$106M
$1.82M 0.29%
+63,300
New +$1.99M
AVNT icon
106
Avient
AVNT
$4.16B
$1.81M 0.29%
59,785
-2,266
-4% -$93.9K
JNJ icon
107
Johnson & Johnson
JNJ
$629B
$1.79M 0.29%
10,984
-632
-5% -$107K
B
108
Barrick Mining
B
$67.9B
$1.79M 0.29%
115,452
-4,133
-3% -$65.2K
CTVA icon
109
Corteva
CTVA
$50.4B
$1.79M 0.29%
31,260
BIIB icon
110
Biogen
BIIB
$30.9B
$1.78M 0.28%
6,674
+2,130
+47% +$452K
DZSI
111
DELISTED
DZS Inc. Common Stock
DZSI
$1.77M 0.28%
156,383
+4,347
+3% +$61.6K
TTI icon
112
TETRA Technologies
TTI
$1.29B
$1.77M 0.28%
492,007
+159,754
+48% +$630K
CLPT icon
113
ClearPoint Neuro
CLPT
$463M
$1.75M 0.28%
168,939
+63,349
+60% +$835K
PG icon
114
Procter & Gamble
PG
$335B
$1.73M 0.28%
13,684
-27
-0.2% -$3.83K
SPWR
115
DELISTED
SunPower Corporation Common Stock
SPWR
$1.71M 0.27%
74,199
+5,420
+8% +$122K
DE icon
116
Deere & Co
DE
$167B
$1.7M 0.27%
5,091
MTDR icon
117
Matador Resources
MTDR
$6.5B
$1.7M 0.27%
34,657
+978
+3% +$52.8K
INST
118
DELISTED
Instructure Holdings, Inc.
INST
$1.69M 0.27%
76,033
+5,572
+8% +$130K
LTRX icon
119
Lantronix
LTRX
$275M
$1.67M 0.27%
346,479
+9,787
+3% +$59.5K
EVH icon
120
Evolent Health
EVH
$471M
$1.67M 0.27%
46,333
+3,369
+8% +$119K
LLY icon
121
Eli Lilly
LLY
$1.09T
$1.65M 0.26%
5,090
-1,171
-19% -$371K
LXFR icon
122
Luxfer Holdings
LXFR
$457M
$1.61M 0.26%
110,932
+3,041
+3% +$48.2K
GTES icon
123
Gates Industrial Corporation Ltd.
GTES
$7.05B
$1.6M 0.26%
164,215
-1,059
-0.6% -$12K
EFOR
124
Everforth Inc
EFOR
$1.34B
$1.6M 0.26%
17,732
-1,350
-7% -$131K
BABA icon
125
Alibaba
BABA
$300B
$1.58M 0.25%
19,746
+5,348
+37% +$510K

Similar funds

Essex Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, Essex Investment Management held 446 positions worth $627M, up 1.2% from $619M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Essex Investment Management's Q3 2022 filing shows 23 new, 113 increased, 92 reduced and 35 closed positions. Its largest new stake was Axogen: 327,698 shares worth $3.91M. The largest sale was Cowen Inc. Class A Common Stock, an estimated $9.39M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

  • Essex Investment Management's largest Q3 2022 buy was Axogen: 327,698 shares worth $3.91M.
  • Essex Investment Management added most to Salesforce in Q3 2022, an estimated $5.01M increase.
  • Essex Investment Management's biggest Q3 2022 reduction was Cowen Inc. Class A Common Stock, cutting an estimated $9.39M.
  • Essex Investment Management fully exited Sierra Wireless in Q3 2022, selling an estimated $4.9M.
  • Essex Investment Management's ten largest holdings make up 18% of its $627M portfolio in Q3 2022.
  • Essex Investment Management opened 23 new positions and closed 35 in Q3 2022.
  • Essex Investment Management's portfolio value rose 1.2% quarter-over-quarter to $627M.

Based on Essex Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.